Diaceutics (LON:DXRX) Stock Price Up 0.8% – Still a Buy?

Diaceutics PLC (LON:DXRX)’s stock price rose 0.8% during mid-day trading on Friday . The company traded as high as GBX 120 ($1.65) and last traded at GBX 119.48 ($1.64). Approximately 72,885 shares traded hands during trading, a decline of 43% from the average daily volume of 127,715 shares. The stock had previously closed at GBX 118.50 ($1.63).

Diaceutics Stock Performance

The company has a debt-to-equity ratio of 0.39, a quick ratio of 9.92 and a current ratio of 4.85. The firm’s 50 day moving average is GBX 125.28 and its 200-day moving average is GBX 128.97. The firm has a market cap of £100.83 million, a price-to-earnings ratio of -35.44 and a beta of 0.58.

Diaceutics (LON:DXRX) last released its quarterly earnings data on Tuesday, May 13th. The company reported GBX (2.02) (($0.03)) earnings per share (EPS) for the quarter. Diaceutics had a negative net margin of 10.90% and a negative return on equity of 7.15%. Sell-side analysts anticipate that Diaceutics PLC will post 1.0107919 earnings per share for the current fiscal year.

Insider Activity at Diaceutics

In related news, insider Peter Keeling sold 500,000 shares of Diaceutics stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of GBX 126 ($1.73), for a total value of £630,000 ($864,553.31). 34.30% of the stock is owned by company insiders.

About Diaceutics

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.